|
|
| Biotechnologies Et Génétique > Etude de marché sectorielle |
|
|
|
|
€ 1 400,00 |
Editeur
: |
ZZZ - Biovista |
Langue
: |
Anglais |
Date de publication : |
Décembre 2000 |
Taille du document : |
150 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (1) |
|
|
|
| 53 pages | Janvier 2007 | Anglais
|
|
|
| Main
focus: |
bioinformatics,genomics,human genome,biotechnology,...,...
|
| Research
focus: |
market size and estimates,market definition, |
| Geographic
focus: |
usa,singapore,united kingdom,australia |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Biotechnology Business and Market Analysis 30 pages | Octobre 2002 |
The growing biotechnology industry and its sectors like – agriculture, marine sciences, human therapeutics, and the environment are aiding long-term economic growth. Biotechnology is creating new p |
500,00 €
|
| |
| |
03-026: The Market for Tissue Microarrays 134 pages | Juillet 2003 |
This report provides vital information on end-users’ scientific objectives, instrumentation for production and analysis of TMAs, outsourcing practices and preferred TMA suppliers |
640,00 €
|
| |
| |
03-052A: Protein Purification Systems: Market Opportunities for Research Product Suppliers 163 pages | Octobre 2003 |
This report will help suppliers exploit opportunities to differentiate themselves from their competitors and develop more advanced protein purification tools |
960,00 €
|
| |
| |
03-011: The Market for Real-Time PCR Reagents & Instrumentation 180 pages | Avril 2003 |
Based on a detailed 52-question survey of 406 scientists who currently perform qPCR, this report describes their research interests and specific applications |
640,00 €
|
| |
| |
The Pharmacogenomics Outlook 174 pages | Août 2000 |
Pharmaceutical companies are coming under increasing pressure to increase the quality of their products, and optimize and accelerate drug discovery and development. By identifying differenc |
955,00 €
|
| |
| |
Chinese Markets for Biotechnology 153 pages | Janvier 2002 |
China's demand for biotechnology has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic t |
3 500,00 €
|
| |
| |
Genomic Revolution: Trends & Opportunities 30 pages | Octobre 2002 |
Computational advancements in Genomic technology have brought a revolution in the field of application of Pharmaco-Therapy. Companies are diversifying their business prospect from medical chemistry |
600,00 €
|
| |
| |
Arthritis Drug Discovery IRCD pages | Juin 2001 |
Arthritis (from the Greek for joint) is a chronic multi-factorial disease of the joints, induced when the immune system attacks and begins degrading the joints. The disease knows no racial boun |
1 026,17 €
|
| |
| |
NanoBioTechnology: Trends and Technological Developments 18 pages | Février 2003 |
Nanobiotechnology is being projected as a great scientific and technological opportunity for the Bio world. It is widely recognized as one of the most beneficial areas of nanotechnology to industry |
450,00 €
|
| |
| |
03-038: Clinical Proteomics: A First-Glance Market Report 96 pages | Septembre 2003 |
his First-Glance Market Report identifies the research objectives, methodologies, assay parameters and technological limitations that are currently associated with disease-based protein-profiling stud |
400,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
|
|
Automation has assaulted several levels of biological research generating vast  
  amounts of data. Great leaps in DNA sequencing technology and automation led  
  to a dramatic increase in sequence throughput thus giving birth to the genome  
  sequencing projects, with the culmination this year of the near completion of  
  the human genome sequence.
 
  In addition, advances in the development of high throughput display methods  
  such as microarrays and technical developments in the field of proteomics have  
  enhanced sensitivity and throughput in expression analysis and protein identification.  
  Collectively, these, and other, developments have given rise to the accumulation  
  of vast amounts of biological data at an unprecedented and still fast growing  
  rate.     There has therefore been a need for the development of tools that facilitate  
  the gathering and deposition into specialized databanks of biological data as  
  well as their efficient management and retrieval. In itself, data does not necessarily  
  translate into knowledge. Tools are required to sift through the vast amounts  
  of data in order to extract information in a form that is meaningful to the  
  practitioners in the field, in a process that has now been termed data mining.Beyond  
  data management and analysis, there is a need in modern biology in keeping pace  
  with the rapidly expanding knowledge, for the integration of complex data sets  
  from different sources and at multiple levels. This would require the codification  
  of all biological information, such as cellular pathways, biomolecules and gene  
  data, into a standard syntax, or ontology, that can be used in modeling and  
  simulating biological processes in aiding discovery.     Bionformatics is the scientific discipline that has evolved to fulfill these  
  requirements. Bionformatics can therefore be defined as encompassing all  
  aspects of biological information acquisition, processing, storage, distribution  
  and analysis, combining the methods of mathematics, computer science and  
  biology (Benton, 1996). In practical terms, bioinformatics involves the application  
  of information technology for the gathering, management and analysis of biological  
  data, which translates into databases and their search and analysis software  
  tools that have become an essential part of todays biological research  
  environment.
|
|
EXECUTIVE SUMMARY
1. INTRODUCTION
1.1. What is Bioinformatics?
1.2. Historical Perspective
1.3. What is Bioinformatics Used For?
2. APPROACHES AND TOOLS
2.1. DNA Sequence Assembly
2.2. Expression Profiling and Clustering
2.3. Sequence Alignment and Similarity Tools: BLAST and FASTA
2.4. Gene Identification
2.5. Protein Sequence Analysis
2.6. Tools for Protein Pattern Identification and Analysis
3. DATABASES
3.1. DNA Sequence Databases
3.2. EST and Expression Databases
3.3. Protein Sequence Databases
3.4. Protein Structure Databases
3.5. Protein Pattern and Alignment Databases
3.6. ENTREZ
4. BIOINFORMATICS IN DRUG DISCOVERY AND DISEASE
4.1. New Drug Target Identification
4.2. Computational Modeling in Target Identification
4.3. Single Nucleotide Polymorphisms (SNPs)
4.4. Cheminformatics
5. INDUSTRY REPRESENTATIVE PROFILES
5.1. Core Bioinformatics Companies
5.2. Genomics Companies
5.3. Bioinformatics in the Big Pharmas
5.4. Big Pharma Bioinformatics Collaborations
6. BIOINFORMATICS COMPANIES
6.1. Methodology
6.2. Company Listing
7. BIOINFORMATICS PATENTS
7.1. Methodology
7.2. Concise Patent Listing
7.3. Extended Patent Listing
8. THE FUTURE OF BIOINFORMATICS
8.1. Bioinformatics in the Post-Genomic Era
8.2. Data Mining
8.3. Current Challenges
|
|
|
PPLSEN
|
|
|
|
|